Interestingly, the membrane-bound metalloprotease, ADAM17, is capable of promoting the cleavage of intracellular CD44 and enhanced stemness in glioma cells via the activation of HIF-2α signaling [36]. Here, ADAM17 is linked to central nervous system cancer.